These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15380190)

  • 41. Slow-binding human serine racemase inhibitors from high-throughput screening of combinatorial libraries.
    Dixon SM; Li P; Liu R; Wolosker H; Lam KS; Kurth MJ; Toney MD
    J Med Chem; 2006 Apr; 49(8):2388-97. PubMed ID: 16610782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis of novel pyrrolidine 3,4-diol derivatives as inhibitors of alpha-L-fucosidases.
    Moreno-Clavijo E; Carmona AT; Vera-Ayoso Y; Moreno-Vargas AJ; Bello C; Vogel P; Robina I
    Org Biomol Chem; 2009 Mar; 7(6):1192-202. PubMed ID: 19262940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A fluorescence study of isofagomine protonation in β-glucosidase.
    Lindbäck E; Laursen BW; Poulsen JC; Kilså K; Pedersen CM; Bols M
    Org Biomol Chem; 2015 Jun; 13(23):6562-6. PubMed ID: 25978843
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spirocyclopropyl pyrrolidines as a new series of alpha-L-fucosidase inhibitors.
    Laroche C; Behr JB; Szymoniak J; Bertus P; Schütz C; Vogel P; Plantier-Royon R
    Bioorg Med Chem; 2006 Jun; 14(12):4047-54. PubMed ID: 16488612
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Strategy for discovering chemical inhibitors of human cyclophilin a: focused library design, virtual screening, chemical synthesis and bioassay.
    Li J; Zhang J; Chen J; Luo X; Zhu W; Shen J; Liu H; Shen X; Jiang H
    J Comb Chem; 2006; 8(3):326-37. PubMed ID: 16677001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanistic differences in inhibition of ubiquinol cytochrome c reductase by the proximal Qo-site inhibitors famoxadone and methoxyacrylate stilbene.
    Pember SO; Fleck LC; Moberg WK; Walker MP
    Arch Biochem Biophys; 2005 Mar; 435(2):280-90. PubMed ID: 15708371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expanding the library of divalent fucosidase inhibitors with polyamino and triazole-benzyl bridged bispyrrolidines.
    Hottin A; Carrión-Jiménez S; Moreno-Clavijo E; Moreno-Vargas AJ; Carmona AT; Robina I; Behr JB
    Org Biomol Chem; 2016 Mar; 14(12):3212-20. PubMed ID: 26906450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
    Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
    Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tight binding inhibitors of N-acyl amino sugar and N-acyl amino acid deacetylases.
    Xu C; Hall R; Cummings J; Raushel FM
    J Am Chem Soc; 2006 Apr; 128(13):4244-5. PubMed ID: 16568996
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amplification of the inhibitory activity and reversal of the selectivity of miglitol by C(2')-monofluorination.
    Prell E; Korb C; Kluge R; Ströhl D; Csuk R
    Arch Pharm (Weinheim); 2010 Oct; 343(10):583-9. PubMed ID: 20941728
    [TBL] [Abstract][Full Text] [Related]  

  • 52. gem-diamine 1-N-iminosugars of L-fucose-type, the extremely potent L-fucosidase inhibitors.
    Shitara E; Nishimura Y; Kojima F; Takeuchi T
    Bioorg Med Chem; 2000 Feb; 8(2):343-52. PubMed ID: 10722157
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two distinct alpha-L-fucosidases from Bifidobacterium bifidum are essential for the utilization of fucosylated milk oligosaccharides and glycoconjugates.
    Ashida H; Miyake A; Kiyohara M; Wada J; Yoshida E; Kumagai H; Katayama T; Yamamoto K
    Glycobiology; 2009 Sep; 19(9):1010-7. PubMed ID: 19520709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overall kinetic mechanism of saccharopine dehydrogenase from Saccharomyces cerevisiae.
    Xu H; West AH; Cook PF
    Biochemistry; 2006 Oct; 45(39):12156-66. PubMed ID: 17002315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis of an alpha-fucosidase inhibitor, 5a-carba-beta-L-fucopyranosylamine, and fucose-type alpha- and beta-DL-valienamine unsaturated derivatives.
    Ogawa S; Watanabe M; Maruyama A; Hisamatsu S
    Bioorg Med Chem Lett; 2002 Mar; 12(5):749-52. PubMed ID: 11858994
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aglycon specificity profiling of alpha-glucosidases using synthetic probes.
    Hakamata W; Muroi M; Kadokura K; Nishio T; Oku T; Kimura A; Chiba S; Takatsuki A
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1489-92. PubMed ID: 15713413
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and biological evaluation of glycosidase inhibitors: gem-difluoromethylenated nojirimycin analogues.
    Wang RW; Qiu XL; Bols M; Ortega-Caballero F; Qing FL
    J Med Chem; 2006 May; 49(10):2989-97. PubMed ID: 16686540
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a UHPLC-MS method for inhibitor screening against α-L-1,3-fucosidase.
    Liu T; Liu R; Zhu L; Zou X; Guan H; Xu Z
    Anal Bioanal Chem; 2019 Mar; 411(7):1467-1477. PubMed ID: 30706074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Harnessing pyrrolidine iminosugars into dimeric structures for the rapid discovery of divalent glycosidase inhibitors.
    Carmona AT; Carrión-Jiménez S; Pingitore V; Moreno-Clavijo E; Robina I; Moreno-Vargas AJ
    Eur J Med Chem; 2018 May; 151():765-776. PubMed ID: 29674295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Crystallographic studies on two bioisosteric analogues, N-acetyl-beta-D-glucopyranosylamine and N-trifluoroacetyl-beta-D-glucopyranosylamine, potent inhibitors of muscle glycogen phosphorylase.
    Anagnostou E; Kosmopoulou MN; Chrysina ED; Leonidas DD; Hadjiloi T; Tiraidis C; Zographos SE; Györgydeák Z; Somsák L; Docsa T; Gergely P; Kolisis FN; Oikonomakos NG
    Bioorg Med Chem; 2006 Jan; 14(1):181-9. PubMed ID: 16213146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.